Effect of the Statistical Significance of Results on the Time to Completion and Publication of Randomized Efficacy Trials
JAMAPublished 28 January 1998
John P. A. Ioannidis
Citations629
SJR quartileQ1
SJR score5.35
SNIP10.71
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
There is a time lag in the publication of negative findings that occurs mostly after the completion of the trial follow-up among randomized efficacy trials.
Abstract
Among randomized efficacy trials, there is a time lag in the publication of negative findings that occurs mostly after the completion of the trial follow-up.
Keywords
Decision SciencesMathematics
BiometricsA Multiple Testing Procedure for Clinical Trials
3,349 Citations1979Peter C. O’Brien, Thomas R. Fleming
The overall size of the procedure is shown to be controlled with virtually the same accuracy as the single sample chi-square test based on N(m1 + m2) observations and the power is found to bevirtually the same.
The LancetPublication bias in clinical research
3,095 Citations1991Philippa Easterbrook, Radha Gopalan +2 more
The presence of publication bias in a cohort of clinical research studies is confirmed and it is suggested that conclusions based only on a review of published data should be interpreted cautiously, especially for observational studies.
JAMAThe Existence of Publication Bias and Risk Factors for Its Occurrence
1,345 Citations1990Kay Dickersin
New England Journal of MedicineZidovudine in Asymptomatic Human Immunodeficiency Virus Infection
1,293 Citations1990Paul A. Volberding, Stephen W. Lagakos +18 more
Zidovudine is safe and effective in persons with asymptomatic HIV infection and fewer than 500 CD4+ cells per cubic millimeter and additional study will be required to determine whether such treatment will ultimately improve survival for persons infected with HIV.
New England Journal of MedicineCumulative Meta-Analysis of Therapeutic Trials for Myocardial Infarction
1,141 Citations1992Joseph Lau, Elliott M. Antman +4 more
Cumulative meta-analysis of therapeutic trials facilitates the determination of clinical efficacy and harm and may be helpful in tracking trials, planning future trials, and making clinical recommendations for therapy.
JAMAFactors Influencing Publication of Research Results
853 Citations1992Kay Dickersin
There was evidence of publication bias in that for both institutional review boards there was an association between results reported to be significant and publication and contrary to popular opinion, publication bias originates primarily with investigators, not journal editors.
Journal of Clinical OncologyPublication bias: the case for an international registry of clinical trials.
758 Citations1986R. J. Simes
A model is proposed for reviewing clinical trial results which is free from publication bias based on the selection of trials registered in advance in a registry, and the value and importance of an international registry of all clinical trials are illustrated.
JAMAWithholding Research Results in Academic Life Science
583 Citations1997David Blumenthal
Withholding of research results is not a widespread phenomenon among life-science researchers, however, withholding is more common among the most productive and entrepreneurial faculty.
The LancetConcorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection
479 Citations1994
There was no statistically significant difference in clinical outcome between the two therapeutic policies of zidovudine treatment in Concorde, and there was a clear difference in changes in CD4 cell count over time in the two groups.
Annals of the New York Academy of SciencesPublication Bias: The Problem That Won't Go Away
429 Citations1993Kay Dickersin, Yuan‐I Min
Meta-analyses performed using data from four prospective investigations in which a total of 997 initiated studies were followed to learn of study results, publication status, and reasons for nonpublication indicate that there is a positive association between "significant" study results and publication.
JAMALarge Trials vs Meta-analysis of Smaller Trials
342 Citations1996Joseph C. Cappelleri
Results of smaller studies are usually compatible with the results of large studies, but discrepancies do occur even when the diversity among both large studies and smaller studies is considered.
New England Journal of MedicineOral Ganciclovir for the Prevention of Cytomegalovirus Disease in Persons with AIDS
310 Citations1996Stephen A. Spector, George McKinley +10 more
In persons with advanced AIDS, phophylactic oral ganciclovir significantly reduces the risk of CMV disease.
PubMedNIH clinical trials and publication bias.
298 Citations1993Kay Dickersin, Yuan‐I Min
Even when the overall publication rate is high, such as for trials funded by the NIH, publication bias remains a significant problem and more reliable systems for maintaining information about initiated studies are needed.
New England Journal of MedicineZidovudine in Persons with Asymptomatic HIV Infection and CD4+ Cell Counts Greater than 400 per Cubic Millimeter
217 Citations1993David A. Cooper, José M. Gatell +10 more
The primary end point was progression of disease, as defined by the development of Centers for Disease Control and Prevention group IV disease, which was changed from the original end point of the acquired immunodeficiency syndrome (AIDS) or advanced AIDS-related complex to...
The LancetBIAS AGAINST THE NULL HYPOTHESIS: THE REPRODUCTIVE HAZARDS OF COCAINE
175 Citations1989Gideon Koren, H. H. Shear +2 more
JAMABias Against Negative Studies in Newspaper Reports of Medical Research
129 Citations1991Gideon Koren
The number, length, and quality of newspaper reporting on the positive study were greater than news reports on the negative study, which suggests a bias against news reports of studies showing no effects or no adverse effects.
PEDIATRICSRetrospective and Prospective Identification of Unpublished Controlled Trials: Lessons From a Survey of Obstetricians and Pediatricians
129 Citations1989Jini Hetherington, Kay Dickersin +2 more
It was concluded that publication bias will not be addressed successfully by attempts to obtain information about unpublished trials retrospectively, but prospective registration of trials at inception appears to be a feasible approach to reducing publication bias and its adverse consequences.
Statistics in MedicineTHE POPULATION RISK AS AN EXPLANATORY VARIABLE IN RESEARCH SYNTHESIS OF CLINICAL TRIALS
128 Citations1996MARTIN W. McINTOSH
This paper represents clinical trials in a bivariate two-level hierarchical model, and demonstrates how to estimate the parameters of the model by both maximum likelihood and Bayes procedures, and shows that using estimates of population risk as fixed covariates will result in bias.
Journal of Clinical EpidemiologyThe impact of high-risk patients on the results of clinical trials
113 Citations1997John P.A. Ioannidis, Joseph Lau
Human immunodeficiency virus-related trials and trials of magnesium in acute myocardial infarction are analyzed and it can be seen that very sick patients of high risk become the major determinants of how many events occur in the whole population.
Annals of Internal MedicineEarly or Deferred Zidovudine Therapy in HIV-Infected Patients without an AIDS-Defining Illness
92 Citations1995John P. A. Ioannidis, Joseph C. Cappelleri +5 more
A meta-analysis of all the available data from double-blind, randomized, placebo-controlled trials that addressed the efficacy of zidovudine as monotherapy in HIV-infected adults without AIDS found that it provided a significant benefit for patients without advanced HIV disease.
JAMADitiocarb Sodium (Diethyldithiocarbamate) Therapy in Patients With Symptomatic HIV Infection and AIDS
87 Citations1991Evan M. Hersh
Ditiocarb was safe and reduced the incidence of opportunistic infections in patients with symptomatic HIV infection and did not induce any major adverse clinical or biological reactions.
AIDSEffects of high-dose oral acyclovir on herpesvirus disease and survival in patients with advanced HIV disease
81 Citations1994M Youle, Brian Gazzard +9 more
High-dose acyclovir failed to reduce the incidence of CMV disease, but significantly reduced the probability of dying at 1 year of follow-up, and there were no notable differences between treatment groups in clinically adverse experiences.
Controlled Clinical TrialsThe Data and Safety Monitoring Board and Acquired immune deficiency syndrome (AIDS) clinical trials
60 Citations1995David L. DeMets, Thomas R. Fleming +12 more
The rationale and operational model for the DSMB may be a useful example for the development of similar review processes in other HIV clinical trial settings and the responsibility, organization, and operating procedures are presented and illustrated.
Controlled Clinical TrialsThe relationship between study design, results, and reporting of randomized clinical trials of HIV infection
44 Citations1997John P.A. Ioannidis, Joseph C. Cappelleri +2 more
Meta-analyses of published trials for specific treatments demonstrated a sizable treatment benefit for all the examined medications regardless of whether these medications were officially approved, controversial, or abandoned, raising concerns about either publication bias or unjustifiable rejection of potentially useful medications.
American Journal of EpidemiologyImpact of Epidemic and Individual Heterogeneity on the Population Distribution of Disease Progression Rates: An Example from Patient Populations in Trials of Human Immunodeficiency Virus Infection
26 Citations1996J. P. A. loannidis, Joseph C. Cappelleri +2 more
By modeling the targeted populations in trials of early versus deferred antiretroviral treatment, the authors observed larger treatment benefits in trials in which rapid progressors probably predominated, compared with trials of slow progressors.